KELSEY MIYASATO-TANIOKA: Open Payments
NPI 1669188132 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 21 payments from 10 companies in 2025. Trend: 2023 $471 · 2024 $208 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| ABBVIE INC. | 2 | $65 |
| Novo Nordisk Inc | 3 | $59 |
| PFIZER INC. | 2 | $55 |
| Exact Sciences Corporation | 2 | $51 |
| Lilly USA, LLC | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Abbott Laboratories | 1 | $13 |
Products named: Kerendia, UBRELVY, PREVNAR 20, Wegovy, MOUNJARO, Cologuard Collection Kit, ROTATEQ, SHINGRIX.
Industry payments across HI — which companies pay providers there.
